they cant really forecast sales. All you can do is look at the size of the market and estimate what % of the mkt they could get.
If the study is successful and they get reg approval, you would expect them to get a decent part of the mkt. Margins are huge too so they could compete on price if needed.
The result of the clinical study should be out soon. Given the results of the previous study I'd say its unlikely this wont be successful. Will be interesting to see what happens.
they cant really forecast sales. All you can do is look at the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
-0.010(3.39%) |
Mkt cap ! $31.90M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.0¢ | 27.5¢ | $148.7K | 524.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17856 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 3306 | 1 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| LTP (ASX) Chart |